carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastična sredstva - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
nibix 100 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 100 mg / 1 kapsula - imatinib
nibix 100 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 100 mg / 1 kapsula - imatinib
nibix 100 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 100 mg / 1 kapsula - imatinib
nibix 100 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 100 mg / 1 kapsula - imatinib
nibix 100 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 100 mg / 1 kapsula - imatinib
nibix 400 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 400 mg / 1 kapsula - imatinib
nibix 400 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 400 mg / 1 kapsula - imatinib
nibix 400 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 400 mg / 1 kapsula - imatinib
nibix 400 mg trde kapsule
adamed sp. z.o.o - imatinib - kapsula, trda - imatinib 400 mg / 1 kapsula - imatinib